MACC1 enhances an oncogenic RNA splicing of IRAK1 through interacting with HNRNPH1 in lung adenocarcinoma

Shiqing Wang,Zhuoshi Li,Chaoqun Chen,Tao Guo,Shilei Zhao,Jinyao Zhao,Wenjing Zhang,Yangfan Qi,Jinrui Zhang,Yang Wang,Yuesheng Lv,Chundong Gu
DOI: https://doi.org/10.1002/jcp.31426
2024-09-04
Journal of Cellular Physiology
Abstract:Depletion of metastasis‐associated in colon cancer 1 (MACC1) suppresses tumor progression through triggering the splicing of IRAK1 from the long isoform IRAK1‐L to the short isoform IRAK1‐S via interacting with hnRNPH1. HnRNPH1 is capable of interacting with the spliced RNA segment (exon 11) of IRAK1 pre‐mRNA to bridge the regulation of IRAK1 by MACC1. Dysregulation of alternative pre‐mRNA splicing plays a critical role in the progression of cancers, yet the underlying molecular mechanisms remain largely unknown. It is reported that metastasis‐associated in colon cancer 1 (MACC1) is a novel prognostic and predictive marker in many types of cancers, including lung adenocarcinoma. Here, we reveal that the oncogene MACC1 specifically drives the progression of lung adenocarcinoma through its control over cancer‐related splicing events. MACC1 depletion inhibits lung adenocarcinoma progression through triggering IRAK1 from its long isoform, IRAK1‐L, to the shorter isoform, IRAK1‐S. Mechanistically, MACC1 interacts with splicing factor HNRNPH1 to prevent the production of the short isoform of IRAK1 mRNA. Specifically, the interaction between MACC1 and HNRNPH1 relies on the involvement of MACC1's SH3 domain and HNRNPH1's GYR domain. Further, HNRNPH1 can interact with the pre‐mRNA segment (comprising exon 11) of IRAK1, thereby bridging MACC1's regulation of IRAK1 splicing. Our research not only sheds light on the abnormal splicing regulation in cancer but also uncovers a hitherto unknown function of MACC1 in tumor progression, thereby presenting a novel potential therapeutic target for clinical treatment.
cell biology,physiology
What problem does this paper attempt to address?